52 Week Range
As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay
Feb 5 (Reuters) - Japan's Gunze Ltd <3002.T>::TO MAKE OSAKA-BASED MEDICAL U&A A WHOLLY OWNED UNIT.
Nov 5(Reuters) - Gunze Ltd <3002.T>:Says it will retire 1.7 million shares (8.1 percent of outstanding) of its common stock on Nov. 26.
Gunze Ltd <3002.T>: Says the co plans to quit from sputtering film production business in Taiwan .Says its Taiwan-based unit, Jun Hong Optronics Corporation, will be dissolved.
Gunze Ltd <3002.T>: Says it plans to sell properties in Tokyo, including land and building . Says the selling price is not disclosed .Says effective March 27.
Gunze Ltd <3002.T> :Says current CHO Atsushi Hirochi will become new president effective April 1.
GUNZE LTD:Says the company amended the consolidated full-year outlook for the FY ended March 2016.Revenue forecast revised to 138,300 million yen from 140,000 million yen.Operating profit forecast revised to 3,600 million yen from 3,200 million yen.Ordinary profit forecast revised to 800 million yen from 3,000 million yen.Net profit forecast revised to a loss of 1,200 million yen from a loss of 6.38 million yen.Earnings per share revised to a loss of 6.38 yen from 1.60 yen.Comments that decreased sales is the main reason for the forecast.Confirmed year-end dividend forecast of 8.5 yen per share for the FY ended March 2016.
GUNZE LTD:Fully acquires a Hiroshima-based clothing firms named Jeans & Casual the dan Co., Ltd. and another Hiroshima-based firm engaged in clothing specialty store operating business, on April 15.
GUNZE LTD:Says the company lowered the consolidated full-year outlook for revenue to 140,000 mln yen from 143,000 mln yen for the fiscal year ending March 31, 2016.Sees a decrease of operating profit forecast to 3,200 mln yen from 3,500 mln yen.Sees a decrease of ordinary profit forecast to 3,000 mln yen from 3,300 mln yen.Sees a decrease of net profit forecast to 300 mln yen from 2,100 mln yen.Sees a decrease of earnings per share to 1.60 yen from 11.17 yen.Comments the sluggish in sale in core business and impairment loss recorded are the main reasons for the forecast.
KOBAYASHI PHARMACEUTICAL CO LTD:To buy Monascus purpureus business from an Osaka-based firm GUNZE LTD on May 31.
GUNZE LTD:Completes repurchase of 5,000,000 shares of its common stock, at the price of 1,647,425,000 yen in total, on July 23.Says plan disclosed on May 13.
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.